Sökresultat - Chong-Rui Xu

Patterns of failure and the subsequent treatment after progression on first-line immunotherapy monotherapy in advanced non-small cell lung cancer: a retrospective study av Jia-Yi Deng, Ming-Yi Yang, Xiao-Rong Yang, Zhi-Hong Chen, Chong-Rui Xu, Qing Zhou

Hämta fulltext

Causal relationship between oral/gut microbiota and lung cancer: a two-sample Mendelian randomization study av Zi-Jian Huang, Lv Wu, Ying-Long Peng, Zhi-Hong Chen, Chong-Rui Xu, Yu Deng, Hong-Hong Yan, Chang Lu, Qing Zhou

Hämta fulltext

Identification of a risk score model based on tertiary lymphoid structure‐related genes for predicting immunotherapy efficacy in non‐small cell lung cancer av Shi‐Qi Mei, Jia‐Qi Liu, Zi‐Jian Huang, Wei‐Chi Luo, Ying‐Long Peng, Zhi‐Hong Chen, Yu Deng, Chong‐Rui Xu, Qing Zhou

Hämta fulltext

Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer av Jia-Yi Deng, Ming Gao, Xue Fan, Hong-Hong Yan, Wei-Chi Luo, Ming-Yi Yang, Xiao-Rong Yang, Zhi-Hong Chen, Chong-Rui Xu, Qing Zhou

Hämta fulltext

Plasma ddPCR for the detection of amplification in advanced NSCLC patients: a comparative real-world study av Jun-Wei Su, Cheng-Di Weng, Xiao-Cheng Lin, Mei-Mei Fang, Xiao Xiao, Yi-Chen Zhang, Xu-Chao Zhang, Jian Su, Chong-Rui Xu, Hong-Hong Yan, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang

Hämta fulltext

Multiple Primary Lung Cancer With Driver Gene Mutations: Is Targeted Therapy Always the Optimal Choice?—A Case Report av Zi‐Rui Ren, Lv Wu, Chang Lu, Fen Wang, Ying‐Long Peng, Dong‐Xuan Cai, Li‐Bo Tang, Jia‐Ting Li, Zhi Guo, Zhi‐Hong Chen, Yu Deng, Lu Sun, Xue‐Wu Wei, Qian‐Lin Huang, Chong‐Rui Xu, Qing Zhou

Hämta fulltext

A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001) av Hua-Jun Chen, Hai-Yan Tu, Yanping Hu, Yun Fan, Guowu Wu, Shundong Cang, Yi Yang, Nong Yang, Rui Ma, Gaowa Jin, Ximing Xu, Anwen Liu, Shubin Tang, Ying Cheng, Yan Yu, Chong-Rui Xu, Qing Zhou, Yi-Long Wu

Hämta fulltext

Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS) av Anna Li, Wei-Neng Feng, Juan Li, Bing-Fei Xu, Jun Zhao, Yun Jia, Ke-Jing Tang, Yong-Sheng Li, Cheng-Zhi Zhou, Yun Fan, Chong-Rui Xu, Yue-Li Sun, Hua-Jun Chen, Hong-Hong Yan, Zong-Kun Shi, Jin-Ji Yang

Hämta fulltext

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant non-small cell lung cancer (NEOTIDE/CTONG2104): phase II trial and correlative genomic analysis in ChinaResearch in context av Chao Zhang, Ben-Yuan Jiang, Li-Xu Yan, Li-Shan Peng, Jin-Hu Li, Zhi-Yong Chen, Yu-Xuan Sun, Jian Su, Ri-Qiang Liao, Song Dong, Hong-Hong Yan, Chong-Rui Xu, Qing Zhou, Xue-Ning Yang, Zheng Hu, Yi-Long Wu, Wen-Zhao Zhong

Hämta fulltext

Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinom... av Xue-Wu Wei, Chang Lu, Yi-Chen Zhang, Xue Fan, Chong-Rui Xu, Zhi-Hong Chen, Fen Wang, Xiao-Rong Yang, Jia-Yi Deng, Ming-Yi Yang, Qing Gou, Shi-Qi Mei, Wei-Chi Luo, Ri-Wei Zhong, Wen-Zhao Zhong, Jin-Ji Yang, Xu-Chao Zhang, Hai-Yan Tu, Yi-Long Wu, Qing Zhou

Hämta fulltext

Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective study av Chang Lu, Chong-Rui Xu, Yi-Chen Zhang, E-E Ke, Yue-Li Sun, Xiao-Yan Bai, Zhi-Hong Chen, Jian Su, Yu Deng, Ting Hou, Fei Zhao, Min Li, Bin-Chao Wang, Hai-Yan Tu, Zhen Wang, Xu-Chao Zhang, Hua-Jun Chen, Jin-Ji Yang, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu

Hämta fulltext

Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer av Wei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, Zhi-Hong Chen, Yi-Chen Zhang, Ming-Yi Yang, Jia-Qi Liu, Jing-Yan Xu, Xiao-Rong Yang, Ri-Wei Zhong, Li-Bo Tang, Lin-Xi Yin, Yu Deng, Ying-Long Peng, Chang Lu, Bao-Long Chen, Dong-Xian Ke, Hai-Yan Tu, Jin-Ji Yang, Chong-Rui Xu, Yi-Long Wu, Qing Zhou

Hämta fulltext

Genomic and immune characteristics of HER2‐mutated non‐small‐cell lung cancer and response to immune checkpoint inhibitor‐based therapy av Hai‐Yan Tu, Kai Yin, Xiaotian Zhao, E‐E Ke, Si‐Pei Wu, Yang‐Si Li, Mei‐Mei Zheng, Si‐Yang Maggie Liu, Chong‐Rui Xu, Yue‐Li Sun, Jia‐Xin Lin, Xiao‐Yan Bai, Yi‐Chen Zhang, Qing Zhou, Jin‐Ji Yang, Wen‐Zhao Zhong, Bing‐Chao Wang, Xu‐Chao Zhang, Dongqin Zhu, Lingling Yang, Qiuxiang Ou, Yi‐Long Wu

Hämta fulltext

Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases av Peng Li, Zhen Wang, Qing Zhou, Yi-Long Wu, Hao Sun, Zhi-Hong Chen, Xu-Chao Zhang, Wen-zhao Zhong, Hong-Hong Yan, Zhong-Yi Dong, Liang Li, Kai Yin, Xue-Ning Yang, Yi Pan, Chong-Rui Xu, Si-Yang Maggie Liu, Yangqiu Li, Yang-Si Li, Wenpu Lai, Hai-Yan Tu, Shou-Heng Lin, De-Xiang Zhou, Wei-Bang Guo, Jin-Ji Yang, Ben-Yuan Jiang, Bin-Chao Wang, Hua-Jun Chen, Lu Zeng, Oscar Junhong Luo, Mei-Mei Zheng

Hämta fulltext